Mine sisu juurde

zafirlukast

Lehekülje sisu ei toetata teistes keeltes.

keemiline ühend

Välised allikad

CAS Registry Number
Microsoft Academic ID
PubChem CID
DSSTOX compound identifier
UniChem compound ID
LiverTox ID
PDB ligand ID
KEGG ID
OpenAlex ID
ChEMBL ID
InChIKey
DrugBank ID
DSSTox substance ID
ChEBI ID
10100[8][11]

mapping relation type: täpne vaste

WikiProjectMed ID
ATC code
UMLS CUI
SureChEMBL ID
Guide to Pharmacology Ligand ID
Reaxys registry number
3641829[6]
NDF-RT ID
SPLASH
InChI
ECHA Substance Infocard ID
ChemSpider ID
EC number
663-705-8[16]
Human Metabolome Database ID
DrugCentral ID
Freebase
MeSH descriptor ID
MedlinePlus drug identifier
RxNorm ID
Probes And Drugs ID
UNII

üksikjuht nähtusest

type of chemical entity

mille alamklass

kasutus

keemiline struktuur

mass/kaal

575,209007 aatommassiühik[20]

chemical formula

C₃₁H₃₃N₃O₆S[3]

canonical SMILES

CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC[3]

defined daily dose

40 milligram[21]

route of administration: oral administration

active ingredient in

Accolate[22]

World Health Organisation international non-proprietary name

zafirlukast[6]

medical condition treated

bronhiaalastma[24]

approved by: FDA

algusaeg: 25. september 1996

physically interacts with

Cysteinyl leukotriene receptor 1[25]

subjektil on roll: Antagonist

Cysteinyl leukotriene receptor 2[25]

subjektil on roll: Antagonist

pregnancy category

Australian pregnancy category B1
US pregnancy category B

LiverTox likelihood score

LiverTox toxicity likelihood category C[26]

subjektil on roll

anti-asthmatic agents[27]
leukotriene antagonists[27]

Commonsi kategooria

Zafirlukast

Viited

  1. 1,0 1,1 1,2 1,3 1,4 Global Substance Registration System, 19. november 2016, inglise keel, zafirlukast, XZ629S5L50
  2. CAS Common Chemistry, 9. aprill 2021, YEEZWCHGZNKEEK-UHFFFAOYSA-N, https://commonchemistry.cas.org/detail?cas_rn=107753-78-6
  3. 3,0 3,1 3,2 3,3 3,4 PubChem, 19. november 2016, inglise keel, 5717, zafirlukast
  4. 4,0 4,1 4,2 4,3 4,4 4,5 YEEZWCHGZNKEEK-UHFFFAOYSA-N, InChIKey
  5. 5,0 5,1 UniChem
  6. 6,0 6,1 6,2 6,3 ChEBI, 3. oktoober 2016, inglise keel, zafirlukast, 10100
  7. OpenAlex, 26. jaanuar 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
  8. 8,0 8,1 ChEMBL, 19. november 2016, inglise keel, ZAFIRLUKAST, CHEMBL603
  9. ChEBI release 2020-09-01
  10. Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
  11. International Chemical Identifier, InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)
  12. DrugBank, inglise keel, 17. november 2015, 00549, Zafirlukast
  13. UMLS 2023, 25. mai 2023, inferred by common MeSH mappings on source and on Wikidata
  14. 14,0 14,1 inferred from InChIKey
  15. IUPHAR/BPS Guide to PHARMACOLOGY, 19. november 2016, inglise keel, 3322, zafirlukast
  16. 16,0 16,1 ECHA Substance Infocard database, 27. detsember 2018, 100.189.989, cyclopentyl N-[3-({2-methoxy-4-[(2-methylbenzenesulfonyl)carbamoyl]phenyl}methyl)-1-methyl-1H-indol-5-yl]carbamate, CAS no.: 107753-78-6
  17. ChemSpider, 19. november 2016, inglise keel, 5515, Zafirlukast
  18. Freebase Data Dumps, 28. oktoober 2013
  19. Medical Subject Headings, 14. märts 2018, C062735
  20. PubChem, 3. oktoober 2016, inglise keel, 5717, zafirlukast
  21. https://www.whocc.no/atc_ddd_index/?code=R03DC01
  22. RxNorm, 135092, 14. veebruar 2018
  23. N0000148457, 13. detsember 2016, NDF-RT, inglise keel
  24. Inxight: Drugs Database, 2. november 2018, https://drugs.ncats.io/drug/XZ629S5L50, http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020547s027lbl.pdf
  25. 25,0 25,1 IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 3322, inglise keel
  26. LiverTox, 8. aprill 2021, https://www.ncbi.nlm.nih.gov/books/n/livertox/Zafirlukast, 4. juuni 2019
  27. 27,0 27,1 Medical Subject Headings, 15. märts 2018, C062735